Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

[Guidelines of the Chilean Endocrinology Society for the correct clinical use of bone densitometry].

Barberán M M, Campusano M C, Trincado M P, Oviedo G S, Brantes G S, Sapunar Z J, Canessa J, Cid P, Escobar F, Eugenin D, Florenzano P, Gajardo H, González G, Illanes F, Jiménez B, Martínez C, Miranda E, Rivera S, Salman P.

Rev Med Chil. 2018 Dec;146(12):1471-1480. doi: 10.4067/s0034-98872018001201471. Spanish.

2.

Recovery of a Common Bean Landrace (Phaseolus vulgaris L.) for Commercial Purposes.

Mallor C, Barberán M, Aibar J.

Front Plant Sci. 2018 Oct 25;9:1440. doi: 10.3389/fpls.2018.01440. eCollection 2018.

3.

[Study and management of thyroid nodes by non specialist physicians: SOCHED consensus].

Tala H, Díaz RE, Domínguez Ruiz-Tagle JM, Sapunar Zenteno J, Pineda P, Arroyo Albala P, Barberán M, Cabané P, Cruz Olivos F, Gac E P, Glasinovic Pizarro A, González HE, Grob F, Hidalgo Valle MS, Jaimovich R, Lanas A, Liberman C, Lobo Guiñez M, Madrid A.

Rev Med Chil. 2017 Aug;145(8):1028-1037. doi: 10.4067/s0034-98872017000801028. Spanish.

4.

[False negative spect parathyroid scintigraphy with sestamibi in patients with primary hyperparathyroidism].

Paillahueque G, Massardo T, Barberán M, Ocares G, Gallegos I, Toro L, Araya AV.

Rev Med Chil. 2017 Aug;145(8):1021-1027. doi: 10.4067/s0034-98872017000801021. Spanish.

5.

Resveratrol therapeutics combines both antimicrobial and immunomodulatory properties against respiratory infection by nontypeable Haemophilus influenzae.

Euba B, López-López N, Rodríguez-Arce I, Fernández-Calvet A, Barberán M, Caturla N, Martí S, Díez-Martínez R, Garmendia J.

Sci Rep. 2017 Oct 16;7(1):12860. doi: 10.1038/s41598-017-13034-7.

6.

[Clinical features of patients with Basedow Graves disease seen at a university hospital].

Lanas A, Díaz P, Eugenin D, González F, Cid P, Cordero F, Araya V, Liberman C, Barberan M, Gac P, Saldías N, Pineda P.

Rev Med Chil. 2017 Apr;145(4):436-440. doi: 10.4067/S0034-98872017000400003. Spanish.

7.

Inactivation of the Thymidylate Synthase thyA in Non-typeable Haemophilus influenzae Modulates Antibiotic Resistance and Has a Strong Impact on Its Interplay with the Host Airways.

Rodríguez-Arce I, Martí S, Euba B, Fernández-Calvet A, Moleres J, López-López N, Barberán M, Ramos-Vivas J, Tubau F, Losa C, Ardanuy C, Leiva J, Yuste JE, Garmendia J.

Front Cell Infect Microbiol. 2017 Jun 20;7:266. doi: 10.3389/fcimb.2017.00266. eCollection 2017.

8.

25-Hydroxyvitamin D deficiency among anaesthesiologists and anaesthesiology residents in Chile.

Aguilera G, Barberán M, Vargas J, Maldonado F, Brunet L, Caamaño E, Albornoz D, León M.

Br J Anaesth. 2017 Jun 1;118(6):951-952. doi: 10.1093/bja/aex147. No abstract available.

9.

Association between non-melanoma and melanoma skin cancer rates, vitamin D and latitude.

Rivas M, Rojas E, Calaf GM, Barberán M, Liberman C, De Paula Correa M.

Oncol Lett. 2017 May;13(5):3787-3792. doi: 10.3892/ol.2017.5898. Epub 2017 Mar 23.

10.

Clinical and cognitive insight in patients with psychosis. Is there a relationship?

Pedrós A, Andreu M, Vilaplana A, Pomares T, Sorribes G, Barberán M, Tomás A, Tordera V, Matínez P.

Schizophr Res. 2018 Feb;192:467-468. doi: 10.1016/j.schres.2017.04.022. Epub 2017 Apr 29. No abstract available.

PMID:
28461118
11.

Relationship between azithromycin susceptibility and administration efficacy for nontypeable Haemophilus influenzae respiratory infection.

Euba B, Moleres J, Viadas C, Barberán M, Caballero L, Grilló MJ, Bengoechea JA, de-Torres JP, Liñares J, Leiva J, Garmendia J.

Antimicrob Agents Chemother. 2015 May;59(5):2700-12. doi: 10.1128/AAC.04447-14. Epub 2015 Feb 23.

12.

Clinical and histological features of brucellin skin test responses in Brucella suis biovar 2 infected pigs.

Dieste-Pérez L, Barberán M, Muñoz PM, Moriyón I, Blasco JM.

Vet Immunol Immunopathol. 2015 Jan 15;163(1-2):77-85. doi: 10.1016/j.vetimm.2014.11.009. Epub 2014 Nov 20.

PMID:
25480681
13.

Studies on a suitable antibiotic therapy for treating swine brucellosis.

Dieste-Pérez L, Fraile L, de Miguel MJ, Barberán M, Blasco JM, Muñoz PM.

J Vet Pharmacol Ther. 2015 Aug;38(4):357-64. doi: 10.1111/jvp.12189. Epub 2014 Nov 21.

PMID:
25413993
14.

Brucella ceti infection in dolphins from the Western Mediterranean sea.

Isidoro-Ayza M, Ruiz-Villalobos N, Pérez L, Guzmán-Verri C, Muñoz PM, Alegre F, Barberán M, Chacón-Díaz C, Chaves-Olarte E, González-Barrientos R, Moreno E, Blasco JM, Domingo M.

BMC Vet Res. 2014 Sep 17;10:206. doi: 10.1186/s12917-014-0206-7.

15.

In vivo monitoring of Staphylococcus aureus biofilm infections and antimicrobial therapy by [18F]fluoro-deoxyglucose-MicroPET in a mouse model.

Garrido V, Collantes M, Barberán M, Peñuelas I, Arbizu J, Amorena B, Grilló MJ.

Antimicrob Agents Chemother. 2014 Nov;58(11):6660-7. doi: 10.1128/AAC.03138-14. Epub 2014 Aug 25.

16.

Performance of skin tests with allergens from B. melitensis B115 and rough B. abortus mutants for diagnosing swine brucellosis.

Dieste-Pérez L, Blasco JM, De Miguel MJ, Marín CM, Barberán M, Conde-Álvarez R, Moriyón I, Muñoz PM.

Vet Microbiol. 2014 Jan 10;168(1):161-8. doi: 10.1016/j.vetmic.2013.10.024. Epub 2013 Nov 11.

PMID:
24331743
17.

Relative contributions of lipooligosaccharide inner and outer core modifications to nontypeable Haemophilus influenzae pathogenesis.

Morey P, Viadas C, Euba B, Hood DW, Barberán M, Gil C, Grilló MJ, Bengoechea JA, Garmendia J.

Infect Immun. 2013 Nov;81(11):4100-11. doi: 10.1128/IAI.00492-13. Epub 2013 Aug 26.

18.

Conjunctival vaccination against Brucella ovis in mice with mannosylated nanoparticles.

Da Costa Martins R, Gamazo C, Sánchez-Martínez M, Barberán M, Peñuelas I, Irache JM.

J Control Release. 2012 Sep 28;162(3):553-60. doi: 10.1016/j.jconrel.2012.07.030. Epub 2012 Jul 28.

19.

Determination of the viability of Toxoplasma gondii in cured ham using bioassay: influence of technological processing and food safety implications.

Bayarri S, Gracia MJ, Lázaro R, Pe Rez-Arquillué C, Barberán M, Herrera A.

J Food Prot. 2010 Dec;73(12):2239-43.

PMID:
21219742
20.

Spatial distribution and risk factors of Brucellosis in Iberian wild ungulates.

Muñoz PM, Boadella M, Arnal M, de Miguel MJ, Revilla M, Martínez D, Vicente J, Acevedo P, Oleaga A, Ruiz-Fons F, Marín CM, Prieto JM, de la Fuente J, Barral M, Barberán M, de Luco DF, Blasco JM, Gortázar C.

BMC Infect Dis. 2010 Mar 5;10:46. doi: 10.1186/1471-2334-10-46.

21.

Evaluation of particulate acellular vaccines against Brucella ovis infection in rams.

Da Costa Martins R, Irache JM, Blasco JM, Muñoz MP, Marín CM, Jesús Grilló M, Jesús De Miguel M, Barberán M, Gamazo C.

Vaccine. 2010 Apr 9;28(17):3038-46. doi: 10.1016/j.vaccine.2009.10.073. Epub 2009 Nov 1.

PMID:
19887131
22.

Rough mutants defective in core and O-polysaccharide synthesis and export induce antibodies reacting in an indirect ELISA with smooth lipopolysaccharide and are less effective than Rev 1 vaccine against Brucella melitensis infection of sheep.

Barrio MB, Grilló MJ, Muñoz PM, Jacques I, González D, de Miguel MJ, Marín CM, Barberán M, Letesson JJ, Gorvel JP, Moriyón I, Blasco JM, Zygmunt MS.

Vaccine. 2009 Mar 10;27(11):1741-9. doi: 10.1016/j.vaccine.2009.01.025. Epub 2009 Jan 30.

PMID:
19186196
23.

Efficacy of bp26 and bp26/omp31 B. melitensis Rev.1 deletion mutants against Brucella ovis in rams.

Grilló MJ, Marín CM, Barberán M, de Miguel MJ, Laroucau K, Jacques I, Blasco JM.

Vaccine. 2009 Jan 7;27(2):187-91. doi: 10.1016/j.vaccine.2008.10.065. Epub 2008 Nov 11.

PMID:
19007836
24.

Immunopathological responses and kinetics of Brucella melitensis Rev 1 infection after subcutaneous or conjunctival vaccination in rams.

Muñoz PM, de Miguel MJ, Grilló MJ, Marín CM, Barberán M, Blasco JM.

Vaccine. 2008 May 19;26(21):2562-9. doi: 10.1016/j.vaccine.2008.03.030. Epub 2008 Apr 3.

PMID:
18423950
26.

Isolation of Brucella species from a live-stranded striped dolphin (Stenella coeruleoalba) in Spain.

Muñoz PM, García-Castrillo C, López-Garciá P, González-Cueli JC, De Miguel MJ, Marín CM, Barberán M, Blasco JM.

Vet Rec. 2006 Apr 1;158(13):450-1. No abstract available.

PMID:
16581998
27.

Brucella outer membrane complex-loaded microparticles as a vaccine against Brucella ovis in rams.

Muñoz PM, Estevan M, Marín CM, Jesús De Miguel M, Jesús Grilló M, Barberán M, Irache JM, Blasco JM, Gamazo C.

Vaccine. 2006 Mar 10;24(11):1897-905. Epub 2005 Nov 4.

PMID:
16337315
28.

Chronic meningoencephalitis associated with Brucella sp. infection in live-stranded striped dolphins (Stenella coeruleoalba).

González L, Patterson IA, Reid RJ, Foster G, Barberán M, Blasco JM, Kennedy S, Howie FE, Godfroid J, MacMillan AP, Schock A, Buxton D.

J Comp Pathol. 2002 Feb-Apr;126(2-3):147-52.

PMID:
11945003
29.

A Brucella ovis antigenic complex bearing poly-epsilon-caprolactone microparticles confer protection against experimental brucellosis in mice.

Murillo M, Grilló MJ, Reñé J, Marín CM, Barberán M, Goñi MM, Blasco JM, Irache JM, Gamazo C.

Vaccine. 2001 Jul 20;19(30):4099-106.

PMID:
11457533
30.

Experimental Brucella ovis infection in pregnant ewes.

Grilló MJ, Marín CM, Barberán M, Blasco JM.

Vet Rec. 1999 May 15;144(20):555-8.

PMID:
10371013
31.

Transmission of Brucella melitensis from sheep to lambs.

Grilló MJ, Barberán M, Blasco JM.

Vet Rec. 1997 Jun 7;140(23):602-5.

PMID:
9203318
32.

Antibody and delayed-type hypersensitivity responses to Ochrobactrum anthropi cytosolic and outer membrane antigens in infections by smooth and rough Brucella spp.

Velasco J, Díaz R, Grilló MJ, Barberán M, Marín C, Blasco JM, Moriyón I.

Clin Diagn Lab Immunol. 1997 May;4(3):279-84.

33.

Comparison of two selective media for the isolation of Brucella melitensis from naturally infected sheep and goats.

Marin CM, Jiménez de Bagüés MP, Barberán M, Blasco JM.

Vet Rec. 1996 Apr 27;138(17):409-11.

PMID:
8733178
34.

Thoracic duct drainage.

Duce AM, Sánchez García M, Barberán MT, Vicent JG.

Eur J Surg. 1996 Mar;162(3):241-2. No abstract available.

PMID:
8695741
35.

Endoscopic dacryocystorhinostomy: surgical technique and results.

Sprekelsen MB, Barberán MT.

Laryngoscope. 1996 Feb;106(2 Pt 1):187-9.

PMID:
8583851
36.

The Brucella abortus RB51 vaccine does not confer protection against Brucella ovis in rams.

Jiménez de Bagüés MP, Barberán M, Marín CM, Blasco JM.

Vaccine. 1995 Feb;13(3):301-4.

PMID:
7631517
37.

Brucella ovis infection in two flocks of sheep.

Marco J, González L, Cuervo LA, Beltrán de Heredia F, Barberán M, Marín C, Blasco JM.

Vet Rec. 1994 Sep 10;135(11):254-6.

PMID:
7810048
38.

Evaluation of allergic and serological tests for diagnosing Brucella melitensis infection in sheep.

Blasco JM, Marín C, Jiménez de Bagués M, Barberán M, Hernández A, Molina L, Velasco J, Díaz R, Moriyón I.

J Clin Microbiol. 1994 Aug;32(8):1835-40.

39.

Phase variation of slime production in Staphylococcus aureus: implications in colonization and virulence.

Baselga R, Albizu I, De La Cruz M, Del Cacho E, Barberan M, Amorena B.

Infect Immun. 1993 Nov;61(11):4857-62.

40.

Efficacy of Brucella suis strain 2 vaccine against Brucella ovis in rams.

Blasco JM, Marín C, Jiménez de Bagüés MP, Barberán M.

Vaccine. 1993 Oct;11(13):1291-4.

PMID:
8296481
41.

Evaluation of whole cell and subcellular vaccines against Brucella ovis in rams.

Blasco JM, Gamazo C, Winter AJ, Jiménez de Bagüés MP, Marín C, Barberán M, Moriyón I, Alonso-Urmeneta B, Díaz R.

Vet Immunol Immunopathol. 1993 Aug;37(3-4):257-70.

PMID:
8236802
42.

Role of an intramammary device in protection against experimentally induced staphylococcal mastitis in ewes.

Penadés JR, Albizu I, Baselga R, Marco J, Barberán M, Amorena B.

Am J Vet Res. 1993 May;54(5):732-7.

PMID:
8317765
43.

Evaluation of vaccines and of antigen therapy in a mouse model for Brucella ovis.

Jiménez de Bagüés MP, Marín CM, Barberán M, Blasco JM.

Vaccine. 1993;11(1):61-6.

PMID:
8427038
44.

[Muscular lesions and enzymatic activities in fighting bulls].

Purroy A, García-Belenguer S, Gonzalez JM, Gascón M, Barberán M.

Ann Rech Vet. 1992;23(1):59-62. French.

PMID:
1510339
45.

Comparison of subcutaneous and conjunctival routes of Rev 1 vaccination for the prophylaxis of Brucella ovis infection in rams.

Marín CM, Barberán M, Jiménez de Bagués MP, Blasco JM.

Res Vet Sci. 1990 Mar;48(2):209-15.

PMID:
2110377
46.

Histopathological changes in ewe lambs exposed to prolonged diet on lucerne.

Barberan M, Valderrabano J, Bascuas JA.

Ann Rech Vet. 1990;21(2):161-6.

PMID:
2360775
47.

Efficacy of long-acting oxytetracycline alone or in combination with streptomycin for treatment of Brucella ovis infection of rams.

Marín CM, Jiménez de Bagués MP, Barberán M, Blasco JM.

Am J Vet Res. 1989 Apr;50(4):560-3.

PMID:
2712423
48.

Responses of ewes to B. melitensis Rev1 vaccine administered by subcutaneous or conjunctival routes at different stages of pregnancy.

Jiménez de Bagués MP, Marin CM, Barberán M, Blasco JM.

Ann Rech Vet. 1989;20(2):205-13. Erratum in: Ann Rech Vet 1989;20(3):414.

PMID:
2751232
49.

Immunization with Brucella melitensis Rev 1 against Brucella ovis infection of rams.

Blasco JM, Marín CM, Barberán M, Moriyón I, Díaz R.

Vet Microbiol. 1987 Sep;14(4):381-92.

PMID:
3686824
50.

Pathological features in thymus and thyroids of lambs fed on turnips.

Barberan M, Valderrábano J.

Vet Rec. 1987 Apr 11;120(15):367-8. No abstract available.

PMID:
3590589

Supplemental Content

Loading ...
Support Center